✦ LIBER ✦

Atypical mood stabilizers: a new role for neuroleptics?

✍ Scribed by Gin S Malhi; KN Roy Chengappa; Samuel Gershon; Seyyed N Ghaemi

Book ID: 110906841
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 126 KB
Volume: 13
Category: Article
ISSN: 1398-5647
DOI: 10.1111/j.1399-5618.2011.00967.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Atypical mood stabilizers: a ‘typical’ r

Atypical mood stabilizers: a ‘typical’ role for atypical antipsychotics

✍ G. S. Malhi; M. Berk; M. Bourin; B. Ivanovski; S. Dodd; J. Lagopoulos; P. B. Mit 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Metabolism and Excretion of Mood Stabili

Metabolism and Excretion of Mood Stabilizers and New Anticonvulsants

✍ Terence A. Ketter; Mark A. Frye; Gabriela Corá-Locatelli; Timothy A. Kimbrell; R 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 125 KB

A meta-analysis of mood stabilizers for

A meta-analysis of mood stabilizers for Alzheimer’s disease

✍ Haibing Xiao; Ying Su; Xu Cao; Shenggang Sun; Zhihou Liang 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 Chinese ⚖ 615 KB

Bipolar depression: a new role for atypi

Bipolar depression: a new role for atypical antipsychotics?

✍ Paul E Keck Jr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

Rehospitalization rates of patients with

Rehospitalization rates of patients with bipolar disorder discharged on a mood stabilizer versus a mood stabilizer plus an atypical or typical antipsychotic

✍ Nick C. Patel; M. Lynn Crismon; Michael Pondrom 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 621 KB

Parenteral ziprasidone: a new atypical n

Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?

✍ Matthias Oechsner; Alexei Korchounov 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

This is a report on a case series of five patiens with psychosis in Parkinson's disease who were treated successfully with an intramuscular injection of ziprasidone (10-20 mg) for acute agitation. No deterioration of motor function or other clinically relevant side effects were seen.